Regencell Bioscience Holdings LTD (RGC) — 6-K Filings
All 6-K filings from Regencell Bioscience Holdings LTD. Browse 9 Foreign Current Report reports with AI-powered summaries and risk analysis.
6-K Filings (9)
- 6-K Filing — Apr 17, 2026
- 6-K Filing — Mar 30, 2026
- 6-K Filing — Mar 30, 2026
-
Regencell Bioscience Files Interim Financials for Dec 31, 2024
— Jun 30, 2025 Risk: low
Regencell Bioscience Holdings Limited has filed a Form 6-K on June 30, 2025, to furnish its unaudited condensed consolidated interim balance sheets and statemen -
Regencell Bioscience Completes 38-for-1 Stock Split
— Jun 17, 2025 Risk: low
Regencell Bioscience Holdings Limited announced a 38-for-one forward stock split on June 2, 2025, effective for shareholders of record on that date. This split -
Regencell Bioscience Announces 38-for-1 Stock Split
— Jun 2, 2025 Risk: low
Regencell Bioscience Holdings Limited announced on June 2, 2025, that its board of directors approved a 38-for-one forward stock split, effective for shareholde -
Regencell Extends Director/Employee Stock Lock-up to April 2026
— Jan 15, 2025 Risk: low
Regencell Bioscience Holdings Limited announced on January 15, 2025, that all directors and employees who received stock options have agreed to an extended lock -
Regencell Bioscience Files Interim Financials
— Jun 20, 2024 Risk: low
Regencell Bioscience Holdings Limited has filed a Form 6-K on June 20, 2024, to furnish its unaudited condensed consolidated interim financial statements for th -
Regencell Bioscience: Dr. Chao Resigns, COO Chung Appointed Director
— Jan 2, 2024
Regencell Bioscience Holdings Limited announced a change in its board of directors. Dr. Yi-Chung Chao resigned as a director for personal reasons, effective Dec
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX